Competitive effects of Cochlear-Oticon Medical deal assessed by UK CMA
MLex Summary: The competitive effects of Cochlear’s proposed acquisition of Oticon Medical, the hearing-implant division of Demant, will be assessed by the Competition and Markets Authority during its in-depth investigation of the...To view the full article, register now.
Already a subscriber? Click here to view full article